These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1986925)

  • 21. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Key factors in the rising cost of new drug discovery and development.
    Dickson M; Gagnon JP
    Nat Rev Drug Discov; 2004 May; 3(5):417-29. PubMed ID: 15136789
    [No Abstract]   [Full Text] [Related]  

  • 23. Physician-scientists at risk.
    Montgomery EB
    Science; 1999 Mar; 283(5407):1455-6. PubMed ID: 10206872
    [No Abstract]   [Full Text] [Related]  

  • 24. NIH encourages translational collaboration with industry.
    Wadman M
    Nat Rev Drug Discov; 2010 Apr; 9(4):255-6. PubMed ID: 20224566
    [No Abstract]   [Full Text] [Related]  

  • 25. The significance of health care reform for research, innovations, and academic medicine.
    Pardes H
    Ann N Y Acad Sci; 1994 Nov; 729():132-8; discussion 139-42. PubMed ID: 7998725
    [No Abstract]   [Full Text] [Related]  

  • 26. Scripps to get less from Sandoz.
    Anderson C
    Science; 1994 May; 264(5162):1077. PubMed ID: 8178164
    [No Abstract]   [Full Text] [Related]  

  • 27. Terms of Scripps-Sandoz agreement may be more common than its critics believe.
    Mervis J
    Nature; 1993 Mar; 362(6417):194-5. PubMed ID: 8459840
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug discovery.
    Kennedy D
    Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461
    [No Abstract]   [Full Text] [Related]  

  • 29. Stats and facts. Increasing U.S. health research expenditures.
    Manag Care Interface; 2001 Oct; 14(10):34-5. PubMed ID: 11688091
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmaceutical research: cost savings through innovation.
    Cohen KR; Levy RA
    AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463
    [No Abstract]   [Full Text] [Related]  

  • 31. Costing drug development.
    Nat Rev Drug Discov; 2003 Apr; 2(4):247. PubMed ID: 12680358
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS vaccine 'needs focused effort' as drug firms back off research.
    Butler D
    Nature; 1995 Nov; 378(6555):323-4. PubMed ID: 7477355
    [No Abstract]   [Full Text] [Related]  

  • 33. Patent medicine.
    Baker D
    J Public Health Policy; 2001; 22(3):275-9. PubMed ID: 11603309
    [No Abstract]   [Full Text] [Related]  

  • 34. The NIH budget and the future of biomedical research.
    Loscalzo J
    N Engl J Med; 2006 Apr; 354(16):1665-7. PubMed ID: 16625006
    [No Abstract]   [Full Text] [Related]  

  • 35. Is drug development too slow? NIH to the rescue!
    Weissmann G
    FASEB J; 2011 Apr; 25(4):1119-22. PubMed ID: 21454369
    [No Abstract]   [Full Text] [Related]  

  • 36. NIH 'should rethink pricing clause'.
    Gee H
    Nature; 1994 Dec; 372(6506):488. PubMed ID: 7990910
    [No Abstract]   [Full Text] [Related]  

  • 37. Drugs institute gives grant for cocaine vaccine.
    Nadis S
    Nature; 1996 Aug; 382(6592):568. PubMed ID: 8757117
    [No Abstract]   [Full Text] [Related]  

  • 38. Strengthening biomedicine's roots.
    Dill KA
    Nature; 1999 Jul; 400(6742):309-10. PubMed ID: 10432104
    [No Abstract]   [Full Text] [Related]  

  • 39. The NIH, research institutions and industry: working together on a shared goal.
    Omary MB
    Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
    [No Abstract]   [Full Text] [Related]  

  • 40. Drugs firms inflate research costs, watchdog says.
    Knight J
    Nature; 2001 Aug; 412(6847):571. PubMed ID: 11493879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.